Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generalized pustular psoriasis in a child.

P C van de Kerkhof

    Dermatologica
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    This study details the first use of etretinate (Tigason) to manage generalized pustular psoriasis in a child. Low weekly doses effectively controlled symptoms, leading to a transition to psoriasis vulgaris.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites.

    The Journal of dermatological treatment·2020
    Same author

    Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and influence of body surface area on usage.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2017
    Same author

    Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.

    The British journal of dermatology·2017
    Same author

    Tacalcitol : A Viewpoint by P.C.M. van de Kerkhof.

    Drugs·2016
    Same author

    Calcipotriol cream in the morning and ointment in the evening: a novel regimen to improve compliance.

    The Journal of dermatological treatment·2002
    Same author

    Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.

    The Journal of dermatological treatment·2002
    Same journal

    Radiodermatitis with late ulcer (sarcoma) for 34 years.

    Dermatologica·2010
    Same journal

    Alopecia decalvans, totalis, maligna, with nail changes and tooth abnormalities.

    Dermatologica·2010
    Same journal

    Epidermolysis bullosa tarda simplex.

    Dermatologica·2010
    Same journal

    Blistering after psychological arousal.

    Dermatologica·2010
    Same journal

    Mycosis fungoides in the tumor stage.

    Dermatologica·2010
    Same journal

    Photoallergic rash after Irgafen.

    Dermatologica·2010
    See all related articles

    Area of Science:

    • Dermatology
    • Pediatric Dermatology
    • Pharmacology

    Background:

    • Generalized pustular psoriasis (Zumbusch pattern) is a severe inflammatory skin condition.
    • Management in young children presents unique challenges.
    • Limited treatment options exist for pediatric cases.

    Observation:

    • A young child with generalized pustular psoriasis was treated with etretinate (Tigason).
    • Remarkably low weekly dosages of etretinate were sufficient for disease control.
    • The patient's clinical presentation evolved from Zumbusch pattern to psoriasis vulgaris.

    Findings:

    • Etretinate is effective in managing generalized pustular psoriasis in a pediatric patient.
    • Low-dose etretinate therapy can achieve significant clinical improvement.

    Related Experiment Videos

  • Treatment may induce a transition to a less severe form of psoriasis.

    • Implications:

    • This case suggests etretinate as a potential therapeutic option for pediatric generalized pustular psoriasis.
    • The findings highlight the efficacy of low-dose retinoid therapy in this population.
    • Further research is warranted to explore long-term outcomes and optimal dosing.